Submitted by Anonymous (not verified) on 4 August 2026 - 14:38
Human medicines European public assessment report (EPAR): Vitrakvi, larotrectinib, Date of authorisation: 19/09/2019, Revision: 19, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Vitrakvi, larotrectinib, Date of authorisation: 19/09/2019, Revision: 19, Status: Authorised